Quick Search
General Search Clinical Universe search Industry Universe search
 

Search form

What are you searching for

What are you searching for?
  • Our products
  • Our solutions
What are you searching for?
1 Choose a
FRANCHISE
2 Choose an
APPLICATION
3 Choose a
PRODUCT
E.g., 02/23/2018
E.g., 02/23/2018

BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum

09 October, 2015

FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform

BioFire Receives FDA Clearance for the FilmArray® 2.0 System

26 February, 2015

New system delivers higher throughput, single database management and minimized footprint

BioFire Defense, a bioMérieux company, receives fast-track authorization of FilmArray® Ebola Test

27 October, 2014

Marcy l’Etoile (France) - October 27, 2014 - BioFire Defense, LLC of Salt Lake City, UT announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for its commercial FilmArray® Ebola test (BioThreat-E test™).

bioMérieux VIRTUO™, the new generation of blood culture system, is CE-marked

23 July, 2014

Marcy l'Etoile, France, July 23, 2014 - bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIRTUO™, the new generation of BacT/ALERT®, has been CE-marked. This uniquely innovative automated blood culture microbial detection system further enriches the offering of the BacT/ALERT® product range and is now commercially available in targeted countries that recognize CE marking. The enhanced performance of the system will help laboratories provide rapid results to clinicians to help maximize laboratory efficiency and facilitate better patient outcomes.

Pioneering diagnostics